Clinical Trial: Floseal Treatment for Posterior Epistaxis Study
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Floseal Posterior Epistaxis Pilot Study (PEPIS)
Brief Summary: Effectiveness of Floseal for the treatment of posterior epistaxis.
Detailed Summary: Floseal, a hemostatic agent, is an effective treatment for anterior epistaxis as well as numerous other acute bleeding conditions throughout the body. The investigators hypothesize that Floseal is an effective treatment for posterior epistaxis. If so, then this will also lead to significant cost savings in comparison to any other method of treatment of posterior epistaxis. The investigators have planned a prospective, nonblinded, nonrandomised study with a total of 40 subjects with posterior epistaxis to be included in this study.
Sponsor: Ottawa Hospital Research Institute
Current Primary Outcome: Effectiveness of Floseal for the Treatment of Posterior Epistaxis. [ Time Frame: Immediate effect with 1 hour observation and follow-up at 5 and 30 days following treatment. ]
Original Primary Outcome: Effectiveness of Floseal for the Treatment of Posterior Epistaxis. [ Time Frame: Immediate effect with 1 hour observation and follow-up at 5 and 30 days following treatment. ]
Current Secondary Outcome: Cost Savings of Floseal Treatment in Comparison to Posterior Packing, Surgical, and Embolisation Treatments for Posterior Epistaxis. [ Time Frame: 30 days ]
Original Secondary Outcome: Cost Savings of Floseal Treatment in Comparison to Posterior Packing, Surgical, and Embolisation Treatments for Posterior Epistaxis. [ Time Frame: 30 days ]
Information By: Ottawa Hospital Research Institute
Dates:
Date Received: April 1, 2010
Date Started: April 2010
Date Completion:
Last Updated: January 21, 2015
Last Verified: January 2015